Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Van Daele

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Infection and Drug Resistance|January 17, 2022
Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal FunctionMatthias Gijsen, Omar Elkayal, Pieter Annaert, et al.
The Journal of Antimicrobial Chemotherapy|September 2, 2021
Letermovir exposure in transplant patients with end-stage renal disease on renal replacement therapyNora Isberner, Ruth Van Daele, Hartwig Klinker, et al.
Antibiotics (Basel, Switzerland)|March 25, 2022
Isavuconazole in the Treatment of <i>Aspergillus fumigatus</i> Fracture-Related Infection: Case Report and Literature ReviewBeatrijs Mertens, Ruth Van Daele, Melissa Depypere, et al.
Microorganisms|October 23, 2021
Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill PatientsRuth Van Daele, Joost Wauters, Katrien Lagrou, et al.
Clinical Pharmacokinetics|February 28, 2024
Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in NeonatesDua'a Alrahahleh, Yann Thoma, Ruth Van Daele, et al.
Critical Care (London, England)|July 27, 2022
The impact of extracorporeal membrane oxygenation on the exposure to isavuconazole: a plea for thorough pharmacokinetic evaluationBeatrijs Mertens, Joost Wauters, Yves Debaveye, et al.
Critical Care Medicine|October 13, 2020
Development and External Validation of an Online Clinical Prediction Model for Augmented Renal Clearance in Adult Mixed Critically Ill Patients: The Augmented Renal Clearance PredictorMatthias Gijsen, Chao-Yuan Huang, Marine Flechet, et al.
Medical Mycology|September 20, 2022
Liposomal amphotericin B exposure in critically ill patients: a prospective pharmacokinetic studyRuth Van Daele, Joost Wauters, Omar Elkayal, et al.
Mycoses|May 8, 2021
Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokineticsRuth Van Daele, Yves Debaveye, Robin Vos, et al.
Mycoses|April 19, 2022
Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU studyRuth Van Daele, Joost Wauters, Erwin Dreesen, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Infection and Drug Resistance|January 17, 2022
Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal FunctionMatthias Gijsen, Omar Elkayal, Pieter Annaert, et al.
The Journal of Antimicrobial Chemotherapy|September 2, 2021
Letermovir exposure in transplant patients with end-stage renal disease on renal replacement therapyNora Isberner, Ruth Van Daele, Hartwig Klinker, et al.
Antibiotics (Basel, Switzerland)|March 25, 2022
Isavuconazole in the Treatment of <i>Aspergillus fumigatus</i> Fracture-Related Infection: Case Report and Literature ReviewBeatrijs Mertens, Ruth Van Daele, Melissa Depypere, et al.
Microorganisms|October 23, 2021
Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill PatientsRuth Van Daele, Joost Wauters, Katrien Lagrou, et al.
Clinical Pharmacokinetics|February 28, 2024
Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in NeonatesDua'a Alrahahleh, Yann Thoma, Ruth Van Daele, et al.
Critical Care (London, England)|July 27, 2022
The impact of extracorporeal membrane oxygenation on the exposure to isavuconazole: a plea for thorough pharmacokinetic evaluationBeatrijs Mertens, Joost Wauters, Yves Debaveye, et al.
Critical Care Medicine|October 13, 2020
Development and External Validation of an Online Clinical Prediction Model for Augmented Renal Clearance in Adult Mixed Critically Ill Patients: The Augmented Renal Clearance PredictorMatthias Gijsen, Chao-Yuan Huang, Marine Flechet, et al.
Medical Mycology|September 20, 2022
Liposomal amphotericin B exposure in critically ill patients: a prospective pharmacokinetic studyRuth Van Daele, Joost Wauters, Omar Elkayal, et al.
Mycoses|May 8, 2021
Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokineticsRuth Van Daele, Yves Debaveye, Robin Vos, et al.
Mycoses|April 19, 2022
Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU studyRuth Van Daele, Joost Wauters, Erwin Dreesen, et al.
Pageof 3